Pediatric Growth Hormone Deficiency
Endocrinology
2
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Opko HealthMOD-4023
Opko HealthMOD-4023
PfizerSharps bin to collect used needles/injections
Clinical Trials (3)
Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Start: Dec 2016Est. completion: May 2024
Phase 3Completed
Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Start: Feb 2012Est. completion: Jul 2015
Phase 2Completed
A Study to Compare the Experiences of Taking Daily Growth Hormone Injections to Weekly Ngenla in Children With Low Levels of Growth Hormone
Start: Jan 2024Est. completion: Oct 20250
N/AWithdrawn
Related Jobs in Endocrinology
Research Associate I/II - Biology
Marea Therapeutics
South San Francisco
1w ago
$90K - $120K/yr
Associate Director, Clinical Operations
Marea Therapeutics
South San Francisco
3w ago
$190K - $210K/yr
Associate Director/Director, Regulatory Affairs
Marea Therapeutics
South San Francisco
1mo ago
$185K - $240K/yr
Medical Science Liaison (rare diseases)
Amgen
Poland - Lódz
1mo ago
Senior/Executive Director, Analytical Development
Marea Therapeutics
South San Francisco
1mo ago
$250K - $295K/yr
Senior Clinical Scientist - Job ID: 1845
Ascendis Pharma
Palo Alto, California (Hybrid)
2mo ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space